Diabetes and obesity are indeed risk factors for bladder cancer, and increased rates of glycosuria and urinary tract infections related to SGLT2 inhibitor use may be responsible for the observed increased risk [150]. The gene discussed is SLC5A2; the disease is diabetes mellitus.